rs11667847

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000363.5(TNNI3):​c.11+128T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.186 in 1,573,404 control chromosomes in the GnomAD database, including 29,067 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 4011 hom., cov: 32)
Exomes 𝑓: 0.18 ( 25056 hom. )

Consequence

TNNI3
NM_000363.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.90

Publications

9 publications found
Variant links:
Genes affected
TNNI3 (HGNC:11947): (troponin I3, cardiac type) Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19. [provided by RefSeq, Aug 2020]
TNNI3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • dilated cardiomyopathy 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy 7
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • cardiomyopathy, familial restrictive, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy 1FF
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated restrictive cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 19-55157451-A-G is Benign according to our data. Variant chr19-55157451-A-G is described in ClinVar as Benign. ClinVar VariationId is 1290282.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.32 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNNI3NM_000363.5 linkc.11+128T>C intron_variant Intron 1 of 7 ENST00000344887.10 NP_000354.4 P19429Q6FGX2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNNI3ENST00000344887.10 linkc.11+128T>C intron_variant Intron 1 of 7 1 NM_000363.5 ENSP00000341838.5 P19429
ENSG00000267110ENST00000587871.1 linkn.*131+111T>C intron_variant Intron 5 of 8 5 ENSP00000473050.1 M0R381

Frequencies

GnomAD3 genomes
AF:
0.219
AC:
33254
AN:
151756
Hom.:
4005
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.324
Gnomad AMI
AF:
0.147
Gnomad AMR
AF:
0.155
Gnomad ASJ
AF:
0.173
Gnomad EAS
AF:
0.214
Gnomad SAS
AF:
0.281
Gnomad FIN
AF:
0.199
Gnomad MID
AF:
0.255
Gnomad NFE
AF:
0.172
Gnomad OTH
AF:
0.223
GnomAD4 exome
AF:
0.183
AC:
259569
AN:
1421530
Hom.:
25056
Cov.:
26
AF XY:
0.186
AC XY:
131245
AN XY:
706214
show subpopulations
African (AFR)
AF:
0.335
AC:
10920
AN:
32618
American (AMR)
AF:
0.113
AC:
4938
AN:
43630
Ashkenazi Jewish (ASJ)
AF:
0.172
AC:
4240
AN:
24712
East Asian (EAS)
AF:
0.178
AC:
6990
AN:
39346
South Asian (SAS)
AF:
0.275
AC:
23068
AN:
83974
European-Finnish (FIN)
AF:
0.198
AC:
10364
AN:
52416
Middle Eastern (MID)
AF:
0.264
AC:
1484
AN:
5618
European-Non Finnish (NFE)
AF:
0.172
AC:
185903
AN:
1080450
Other (OTH)
AF:
0.198
AC:
11662
AN:
58766
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
11528
23055
34583
46110
57638
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6664
13328
19992
26656
33320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.219
AC:
33288
AN:
151874
Hom.:
4011
Cov.:
32
AF XY:
0.219
AC XY:
16243
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.325
AC:
13446
AN:
41396
American (AMR)
AF:
0.154
AC:
2357
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.173
AC:
601
AN:
3470
East Asian (EAS)
AF:
0.213
AC:
1092
AN:
5136
South Asian (SAS)
AF:
0.280
AC:
1348
AN:
4810
European-Finnish (FIN)
AF:
0.199
AC:
2098
AN:
10554
Middle Eastern (MID)
AF:
0.236
AC:
69
AN:
292
European-Non Finnish (NFE)
AF:
0.172
AC:
11667
AN:
67912
Other (OTH)
AF:
0.225
AC:
476
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1307
2613
3920
5226
6533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.192
Hom.:
370
Bravo
AF:
0.219
Asia WGS
AF:
0.264
AC:
916
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.5
DANN
Benign
0.15
PhyloP100
-1.9
PromoterAI
-0.080
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11667847; hg19: chr19-55668819; COSMIC: COSV61276040; COSMIC: COSV61276040; API